BioXcel Therapeutics (BTAIQ) Raw Materials (2022 - 2026)
BioXcel Therapeutics (BTAIQ) reported Raw Materials of $408,000 for Q2 2026, down 5.8% from $433,000 a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
BioXcel Therapeutics (BTAIQ) Raw Materials (2022 - 2026) Analysis & Trends
At the end of FY2025, BioXcel Therapeutics posted Raw Materials of $317,000, down 37.4% from FY2024.
- Raw Materials has a three-year compound annual growth rate of -22.5% (FY2022 to FY2025).
- By year, Raw Materials came in at $506,000 in FY2024 (-45.9%), $935,000 in FY2023 (+37.1%) and $682,000 in FY2022.
- Five-year quarterly Raw Materials spans a low of $317,000 in Q4 2025 and a high of $935,000 in Q1 2024.
- Year over year, Raw Materials has now declined in each of the last seven quarters, with an average decline of 28.8% over the last eight quarters.
- The high point for year-over-year Raw Materials in five years was Q1 2024 (growth of 37.1%); the low point was Q3 2025 (a decline of 52.7%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $408,000 (Q1 2026), $317,000 (Q4 2025) and $394,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,230.11 Bn | 1,198.70 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 644.39 Bn | 564.25 Bn | 17.30 Bn |
| 3 | AbbVie | 503.52 Bn | 476.68 Bn | 12.70 Bn |
| 4 | Merck | 363.29 Bn | 317.72 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.23 Bn | 262.62 Bn | 11.24 Bn |
| 6 | Astrazeneca | 267.53 Bn | 241.29 Bn | 12.86 Bn |
| 7 | Amgen | 241.80 Bn | 197.20 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 195.07 Bn | 169.19 Bn | 6.22 Bn |
| 9 | Pfizer | 173.33 Bn | 120.28 Bn | 10.94 Bn |
| 10 | BioXcel Therapeutics | 313,049.99 | -94.30 Mn | 160,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 408,000.00 |
| Mar 31, 2026 | 408,000.00 |
| Dec 31, 2025 | 317,000.00 |
| Sep 30, 2025 | 394,000.00 |
| Jun 30, 2025 | 433,000.00 |
| Mar 31, 2025 | 464,000.00 |
| Dec 31, 2024 | 506,000.00 |
| Sep 30, 2024 | 833,000.00 |
| Jun 30, 2024 | 843,000.00 |
| Mar 31, 2024 | 935,000.00 |
| Dec 31, 2023 | 935,000.00 |
| Sep 30, 2023 | 682,000.00 |
| Jun 30, 2023 | 682,000.00 |
| Mar 31, 2023 | 682,000.00 |
| Dec 31, 2022 | 682,000.00 |
| Sep 30, 2022 | 682,000.00 |
| Jun 30, 2022 | 692,000.00 |
API Access
BioXcel Therapeutics Raw Materials API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=raw-materials&ticker=BTAIQ&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "raw-materials", "ticker": "BTAIQ", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=raw-materials&ticker=BTAIQ&period=max&api_key=YOUR_API_KEY");
const data = await res.json();